
Celoclib 125mg Capsule
Marketer
Celon Laboratories Ltd
Salt Composition
Palbociclib (125mg)
Overview Celoclib 125mg Capsule
For individuals with advanced estrogen receptor-positive, HER2-negative breast cancer, Celoclib 125mg capsules are administered alongside hormonal therapies. This medication, taken with food at the same time daily for optimal effectiveness, requires a doctor-determined dosage and frequency, subject to change based on treatment response. Strict adherence to the prescribed regimen is crucial; improper use or overdose can result in severe adverse effects. While benefits may not be immediately apparent (taking several weeks or months), discontinuation should only occur under medical supervision. Common side effects include tiredness, alopecia, skin rashes, nausea, and diarrhea. Celoclib can lower blood cell counts, increasing infection risk; report fever, chills, weakness, bleeding, or bruising promptly. Dizziness may occur; avoid driving or demanding tasks if affected. Prior to commencing treatment, disclose any pre-existing heart, liver, or kidney conditions, as well as all other medications, including those for infections, to your physician. Numerous drug interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is essential for both partners throughout the treatment period.
Uses of Celoclib 125mg Capsule
Malignant breast tumor
Major Benefits of Celoclib 125mg Capsule:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Consume Celoclib 125mg Capsules with a meal.
Common Side effects of Celoclib 125mg Capsule:
- Decreased blood cells (red cells, white cells, and platelets)
- Fatigue
- Hair loss
- Rash
- Vomiting
- Diarrhea
- Nausea
- Decreased appetite
- Infection
- Decreased white blood cell count
- Stomatitis (Inflammation of the mouth)
- Anemia (low number of red blood cells)
- Weakness
- Fever
How to use Celoclib 125mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume Celoclib 125mg Capsules with a meal.
How Celoclib 125mg Capsule works:
Celoclib 125mg capsules are an anti-cancer drug that functions by targeting the cyclin-dependent kinases 4 and 6 (CDK4/6). These kinases are key components in cellular signaling cascades driving cancer cell growth. By blocking CDK4/6 activity, Celoclib halts the progression of the cell cycle, effectively arresting cancer cell proliferation. Its mechanism further extends to estrogen receptor-positive breast cancers, where it disrupts cell cycle processes.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Celoclib 125mg Capsules may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Celoclib 125mg capsules is contraindicated during pregnancy due to established risk to the fetus. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Lactation and Celoclib 125mg capsules are incompatible. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by Celoclib 125mg Capsules, as they can induce fatigue in certain individuals. Therefore, operating vehicles or machinery requires extra care if such fatigue occurs.
KidneySAFE IF PRESCRIBED
Celoclib 125mg capsules pose no safety concerns for patients with kidney impairment; dose modification is unnecessary.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Celoclib 125mg capsules. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Celoclib 125mg Capsule :
NA
Facts to Know About Celoclib 125mg Capsule
| Label | Value |
|---|---|
| Chemical Type | Piperazine-pyridines |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
| Actions | CDK Inhibitor |
